Vimarsana
Biggest News Aggregation in the World

Christopher Kenney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopher Kenney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopher Kenney Today - Breaking & Trending Today

Judge finds that Columbia's Richland One broke SC's FOIA law | Columbia Education - Vimarsana News

Judge finds that Columbia's Richland One broke SC's FOIA law | Columbia Education

Richland 1 broke the state's Freedom of Information Act, a Richland County judge said in an initial order in a lawsuit against the Columbia SC school district.

Did Richland 1 board violate SC law when discussing stalled project? A judge will decide - Vimarsana News

Did Richland 1 board violate SC law when discussing stalled project? A judge will decide

Aaron Bishop, chair of the Richland 1 school board, testified that he believed the board had complied with state FOIA law.

Source: yahoo.com
Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical ... - Vimarsana News

Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical ...

VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported topline results from the randomized, double-blind, placebo-controlled, Phase 2 proof-of-concept X-NOVA

Xenon drug misses main goal of depression study - Vimarsana News

Xenon drug misses main goal of depression study

BioPharma

Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD) - Vimarsana News

Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)

Conference call today at 8:30 am ETVANCOUVER, British Columbia, Nov. 27, 2023 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today reported topline results from the...